NeoGenomics, Inc. announced two promotions within its senior leadership team, effective immediately. Warren Stone has been promoted to Chief Commercial Officer and will lead NeoGenomics? clinical and pharma services commercial teams. Stone will be responsible for sales, marketing, pharma project management, commercial enablement, scientific affairs, and support functions.

Melody Harris has been promoted to Chief Operations Officer and President, Informatics. In this expanded role, Harris will oversee data-oriented teams and manage all enterprise operations. Stone joined NeoGenomics in 2022 as President of Clinical Services.

He has played a leading role in optimizing NeoGenomics? salesforce and successfully implementing its commercial strategy and digital transformation of systems and tools. Prior to NeoGenomics, Stone served as President of Americas at Ortho Clinical Diagnostics and Senior Vice President, Life Sciences Division for MilliporeSigma.

He holds an MBA from Suffolk University. Harris joined NeoGenomics in 2022 as President of Enterprise Operations. She has led the company through a laboratory transformation including improvements in turnaround time and currently manages the consolidation of several laboratory information management systems (LIMS) into a single system.

Prior to NeoGenomics, Harris served as President and Chief Operating Officer at SomaLogic and held several executive positions at Qualcomm Life?s digital health subsidiary and at HealthyCircles, a healthcare web platform. Harris holds a BA, cum laude, in Political Science from the University of Denver and a JD, cum laude, from Harvard Law School.